MRCAT brain is a software add-on for Philips Ingenia MR systems that generates CT-like images from MR scans to assist in radiation therapy treatment planning for brain tumor patients. It helps clinicians by providing detailed tissue density maps necessary for accurate radiation dose calculations without the need for a separate CT scan.
MRCAT imaging is intended to provide the operator with information of tissue properties for radiation attenuation estimation purposes in photon external beam radiotherapy treatment planning for primary and metastatic brain tumor patients.
MRCAT brain uses a machine learning-based post-processing algorithm embedded in the MR console to generate CT-like images (MRCAT images) from MR mDixon in-phase and water images. Bones and body outline are segmented, and tissue HU values assigned based on fat and water intensities. Uses a convolutional neural network trained with paired CT and MR images. The software runs automatically after the mDixon scan within the MR workflow and exports DICOM images for treatment planning.
Non-clinical verification and validation tests demonstrate compliance with multiple FDA-recognized international standards (including IEC 62304, IEC 62366-1, ISO 14971) and meet acceptance criteria for safety and effectiveness. Clinical robustness shown by gamma analysis for dose plan equivalency between MRCAT and CT-based plans with high accuracy (gamma criteria 1%/1mm).
No predicate devices specified
Submission
11/8/2019
FDA Approval
1/24/2020
Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.
We respect your privacy. Unsubscribe at any time.